Industri

GVRP and Steps Biosciences launch GSRC in Bengaluru for...

The 15,000 sq. ft. Centre of Excellence will support formulation development, ...

Sanofi launches AI agent for field teams using Snowflak...

Concierge for Field prepares sales representatives for physician visits as Sano...

FICCI launches Bharat Life Sciences Awards with Eli Lil...

National platform to recognise contributions in life sciences research, innovat...

The regulatory landscape in India is becoming more stru...

Raay Neo Pharma has officially unveiled its operations with the aim to contribu...

Facility of the Month: New $326 Million Tower at Connec...

The 190,000-square-foot Connecticut Children's tower project marks the largest e...

AbbVie receives EC approval for Aquipta to treat migraine

This marks the second indication for Aquipta in the EU, where it is now approved...

Roche’s giredestrant secures FDA priority review for br...

The application seeks approval of giredestrant as an adjuvant treatment for adul...

Akums receives EDQM CEP approval for Cefpodoxime Proxet...

Certification from the European Directorate for the Quality of Medicines & Heal...

Lupin, Natco receive US FDA approval for Eribulin Mesyl...

ANDA approval covers Eribulin Mesylate Injection, the bioequivalent of Halaven...

Johnson & Johnson launches VARIPULSE platform for AFib ...

Pulsed Field Ablation technology approved for catheter ablation procedures in p...

Alkem launches semaglutide pre-filled syringes in India

Company introduces single-shot pre-filled syringe format for Type 2 diabetes an...

Cape Fear Valley Health Opens Dedicated Adolescent Care...

Cape Fear Valley Health recently celebrated the upcoming opening of Cape Fear Va...

BMS secures FDA acceptance for Camzyos sNDA

The regulator granted the application priority review for this indication, assig...

Servier to acquire Edgewise’s muscular dystrophy busine...

The value includes a $1.55bn upfront payment and as much as $1.1bn in regulatory...

Financial strategies for uncertain times

Inspite of current geopolitical disruptions,both larger pharma enterprises and ...

The winds reshaping Indian pharma supply chains

As the era of hyper-globalisation appears to have run its course,with geopoliti...